Infectious Diseases and Clinical Microbiology

Uzm. Dr. Kamuran Türker

Doctor and researcher Bağcılar Eğitim ve Araştırma Hastanesi İstanbul
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyInfectious Diseases and Clinical Microbiologysaglik.gov.trFrom source
  • Department name at the sourceEnfeksiyon Hast. ve KLNK.MİKROBİYOLOJİsaglik.gov.trFrom source
  • InstitutionBağcılar Eğitim ve Araştırma Hastanesisaglik.gov.trFrom source
  • Publications25 publicationsEurope PMC, OpenAlex, ORCIDFrom source
  • ORCID0000-0002-5050-3832ORCIDFrom source
  • Last synchronised5 November 2026 08:55https://bagcilareah.saglik.gov.tr/TR-1478308/doktorlarimiz.html#kamuran-turkersaglik.gov.tr

Scientific work

Publications

25 publications

  1. Efficacy and Safety of Direct-Acting Antivirals in Patients with Hepatitis C Infection: Nationwide Real-life Data from Türkiye

    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2026

    DOI 10.5152/tjg.2026.25287 PMID 42041139 Open-access full textSource: Europe PMC

  2. Assisting the Diagnosis of Cirrhosis in Chronic Hepatitis C Patients Based on Machine Learning Algorithms: A Novel Non‐Invasive Approach

    Journal of Clinical Laboratory Analysis, 2025

    DOI 10.1002/jcla.70054 PMID 40384539 Open-access full textSource: OpenAlex

  3. Efficacy and Safety of Direct-Acting Antivirals in Elderly Patients with Chronic Hepatitis C: A Nationwide Real-Life, Observational, Multicenter Study from Turkey

    Turkish Journal of Gastroenterology, 2022

    DOI 10.5152/tjg.2022.21271 PMID 35946896 3 citations (Europe PMC) Open-access full textSource: ORCID

  4. In a Real-Life Setting, Direct-Acting Antivirals to People Who Inject Drugs with Chronic Hepatitis C in Turkey

    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2022

    DOI 10.5152/tjg.2022.21834 PMID 36415900 1 citation (Europe PMC) Open-access full textSource: ORCID

  5. Real life efficacy, renal and lipid profile data of tenofovir alafenamide in switched chronic hepatitis B patients

    Journal of Hepatology, 2022

    DOI 10.1016/s0168-8278(22)02013-x 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  6. Direct acting antivirals are effective and safe in intravenous drug users with chronic HCV Preview of your abstract file infection: First report from Turkey

    The Turkish Journal of Gastroenterology, 2019

    DOI 10.5152/tjg.2019.39 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  7. THU-149-Efficiency and safety of direct acting antivirals in chronic hepatitis C patients infected with genotype 2 and 3 in Turkey

    Journal of Hepatology, 2019

    DOI 10.1016/s0618-8278(19)30424-4 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  8. Efficiency and safety of direct acting antivirals in chronic hepatitis C patients ınfected with genotype 2 and 3 in Turkey

    The Turkish Journal of Gastroenterology, 2019

    DOI 10.5152/tjg.2019.38 Open-access full textSource: OpenAlex

  9. Evaluation of Exposures With Rabies Risk Between 2009 and 2014 in Kayseri, Turkey

    Klimik Dergisi/Klimik Journal, 2018

    DOI 10.5152/kd.2018.32 Open-access full textSource: OpenAlex

  10. Direk etkili antivirallerin tedavi deneyimli kronik HCV enfeksiyonu hastalarında etkililiği ve güvenliği: Çok merkezli HEP-C çalışmasının sonuçları

    AYBU AVESIS, 2018

    Source: OpenAlex

View all 25 publications